Overview
Symbiofarm manufactures dietary supplements under contract, from simple preparations to multicomponent and liposomal formulas. The company develops product formulations and selects raw materials, and offers capsules, sachets and liquids, as well as packaging, labeling and product documentation services.
Financials
Revenue history (in m)
Filing timeliness
No financial statement for 2026 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 535 days for 2020).
- 2026not filed
- 202515/07/2026
- 202415/07/2025
- 202301/08/2024
- 202223/05/2024
- 202103/04/2023
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
Each member of the management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paweł Krokage 53 | 12 | $1,620.75 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-10-11.
06 1750 1224 0000 0000 3402 6947- 09 1750 1224 0000 0000 3402 6602
19 1020 4391 0000 6802 0245 0021
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $230.9K$230,902 |
Public aid
20 public aid cases recorded, with a total value of $158,307.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 9, 2026 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | PGE Obrót S.A. | |
| Oct 6, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | –– | STAROSTA STRZYŻOWSKI | |
| Feb 26, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | STAROSTA STRZYŻOWSKI |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Export development of SYMBIOFARM Sp. z o.o. | $89,005$89,005 | Operational Programme Eastern Poland |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Tantussp. z o.o. | $5,274,248.80 | tantus.pl | ||
| Laborellsp. z o.o. | $5,155,995.80 | laborell.pl | ||
| Supplelabsp. z o.o. + limited partnership | $5,146,355.45 | supplelab.pl | ||
| Efferta Blendssp. z o.o. | $3,020,056.75 | efferta.pl | ||
| Proton Labssp. z o.o. | $2,382,339.08 | protonlabs.pl | ||
| Lab88sp. z o.o. | $1,707,981.35 | lab88.pl | ||
| Nutri Partnersp. z o.o. | $1,480,720.01 | nutri-partner.com | ||
| Invent Farmsp. z o.o. | $1,272,446.89 | inventfarm.pl | ||
| Suplement.Iosp. z o.o. | $1,149,843.38 | suplement.io | ||
| Pharmavenesp. z o.o. | $783,187.61 | pharmavene.com |
Change history
| Date | Event | |
|---|---|---|
| 2023-03-28 | PKD change (Removed: 46 codes) | |
| 2011-08-09 | Entered in the register |
FAQ
Last updated: 2026-10-21